Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.5K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.5K
Genetic Variation01:25

Genetic Variation

1.1K
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
1.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Sanger Sequencing01:57

Sanger Sequencing

772.0K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
772.0K
Next-generation Sequencing03:00

Next-generation Sequencing

97.3K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.3K
Genomics02:02

Genomics

39.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lynch syndrome integrative epidemiology and genetics (LINEAGE): rationale for cohort design.

Familial cancer·2026
Same author

Towards a Sustainable Future: Embedding Planetary Health in Allied Health Professional Education Through the Lens of Indigenous Knowledges.

Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals·2026
Same author

A Chatbot to Meet Parents' Information Needs for Sickle Cell Trait Newborn Screening Results: Multiple Methods Formative Study.

Journal of medical Internet research·2026
Same author

Indigenous Culture and Health in UDRH Research: An Indigenous-Led Narrative Review.

The Australian journal of rural health·2026
Same author

Genetic risk of chronic pain conditions associated with risk of suicide death through an integrative analysis of EHR and genomics data.

Translational psychiatry·2026
Same author

Quantifying lifetime risk for 1,401 infectious diseases across the diabetes spectrum using a Bayesian approach.

BMC medicine·2026

Related Experiment Video

Updated: Dec 23, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K

Implementing the VMC Specification to Reduce Ambiguity in Genomic Variant Representation.

Michael Watkins1, Shawn Rynearson1, Alex Henrie1

  • 1Biomedical Informatics, 421 Wakara Way, University of Utah, Salt Lake City, Utah 84108.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|April 21, 2020
PubMed
Summary

Biological sequence variant representation is ambiguous, hindering clinical use. The Variant Modeling Collaboration (VMC) Test Suite offers tools for unambiguous variant representation, improving data standardization and clinical application.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.2K

Related Experiment Videos

Last Updated: Dec 23, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.2K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Current biological sequence variant representation methods lack standardization, leading to data redundancy and inconsistencies.
  • This ambiguity poses challenges for applying variant data to strict clinical standards and interventions.

Purpose of the Study:

  • To implement the GA4GH Variant Modeling Collaboration (VMC) specification for unambiguous biological variant representation.
  • To develop tools that facilitate the adoption of this new standard in genomic data analysis.

Main Methods:

  • Implemented the VMC specification for representing variants at allelic, haplotype, or genotype levels.
  • Developed the VMC Test Suite, including web tools and a command-line interface.
  • Created functionality to generate VMC identifiers, insert them into VCF files, and produce VMC bundle JSON representations.

Main Results:

  • Successfully created the VMC Test Suite, offering practical tools for unambiguous variant representation.
  • Demonstrated the ability to generate and integrate VMC identifiers into VCF files.
  • Enabled the conversion of VCF files and HGVS expressions into VMC bundle JSON format.

Conclusions:

  • The VMC Test Suite provides essential tools for standardizing biological variant representation.
  • Adoption of this standard is crucial for reliable querying of variants and associated annotations.
  • Facilitates the integration of genomic variant data into clinical decision-making processes.